Targeted cancer immunotherapy: Mimicking physiological trans-presentation of IL-15
Under physiological conditions, the trans-presentation of interleukin-15 (IL-15) by the IL-15 receptor α on the cell surface allows to confine and tune the IL-15-mediated immune responses. Therefore, targeting strategies that mimic this situation at the tumor sites appear especially promising for an...
Main Author: | Müller, Dafne |
---|---|
Format: | Online |
Language: | English |
Published: |
Landes Bioscience
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494650/ |
Similar Items
-
Targeting inflammasome/IL-1 pathways for cancer immunotherapy
by: Guo, Beichu, et al.
Published: (2016) -
Coordinate Expression and Trans Presentation of Interleukin (IL)-15Rα and IL-15 Supports Natural Killer Cell and Memory CD8+ T Cell Homeostasis
by: Burkett, Patrick R., et al.
Published: (2004) -
Trans-presentation of IL-15 modulates STAT5 activation and Bcl-6 expression in TH1 cells
by: Cooley, Ian D., et al.
Published: (2015) -
S41. Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer
by: Klein, C
Published: (2014) -
The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases
by: Waldmann, Thomas
Published: (2002)